Literature DB >> 12499721

Ischaemic stroke in young people: a prospective and long-term follow-up study.

Rosella Musolino1, Paolino La Spina, Antonio Granata, Giuseppe Gallitto, Nestore Leggiadro, Scipione Carerj, Agatino Manganaro, Fortunata Tripodi, Antonio Epifanio, Santo Gangemi, Raoul Di Perri.   

Abstract

BACKGROUND: A few studies have comprehensively assessed the epidemiology, aetiology, prognosis, and secondary prevention of ischaemic stroke in young adults. To gain further information on this field, we have prospectively studied a hospital-based series of young adults with a first-ever episode of cerebral ischaemia (CI).
METHODS: Sixty consecutive patients aged 17-45 with ischaemic stroke (55 patients) or transient ischaemic attack within 24 h before hospital admission were recruited and investigated by a standardized rigorous protocol. The patients were followed up for >or=1 year after hospital discharge. Arbitrary doses of aspirin 100 mg/d or ticlopidine 250 mg b.i.d. in case of intolerance to aspirin were given for the secondary prevention. Adjusted-dose oral anticoagulation (INR target 2.5) was used in the presence of cardioembolism or hypercoagulable states. Endpoints included the residual disability, rated by modified Rankin Scale (RS) and Barthel Index (BI), and poststroke recurrence.
RESULTS: CI was associated with two or more risk factors in 61.6% of patients. Cigarette smoking was more frequently associated with male gender (p < 0.05) and migraine history with female sex (p < 0.05). The atherothrombotic diagnostic subtype and the subtype from 'other cause' predominated significantly among patients >or=35 years old (p < 0.05) and <35 years (p < 0.025), respectively. The 'other cause' subset was more frequent in female gender (p < 0.05). Transoesophageal echocardiography (TEE) detected potential cardiac sources of emboli (PCSE) at an extent 3 times higher (p < 0.0001) than transthoracic echocardiography. Congenital heart defects were nearly threefold more frequent than acquired ones, with a prevalence of patent foramen ovale. At a mean of 6.1 +/- 2.6 years (confidence interval 5.4 to 6.8), follow-up data were available for only 54 patients, since five patients were lost and one died in the acute phase. Poststroke recurrence rate was low (7.4%) and no event was fatal. General handicap was severe to moderately severe (RS>3) in 11% of the patients, slight to moderate (1>or=RS<or=3) in 59% and absent in 30% (RS = 0). Functional disability was relatively low with 50% of the patients independent (BI >or=95), 38.9% partially dependent (BI 60 to 86), and 11.1% fully dependent (BI <60). Thirty-seven (68.5%) patients returned to work, although adjustments (other job or part-time employment) were necessary for 10 out of them (27%).
CONCLUSIONS: The present study, though limited by the relatively small number of subjects, suggests that the overall prognosis of ischaemic stroke in young adults is good. We strongly recommend TEE in all patients with ischaemic stroke as an essential tool to increase the detection of PCSE and make the therapeutic approach more efficient. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499721     DOI: 10.1159/000067139

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  16 in total

1.  Thrombophilias and stroke: diagnosis, treatment, and prognosis.

Authors:  Madeline C Fields; Steven R Levine
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

2.  Ischaemic stroke in young adults: predictors of outcome and recurrence.

Authors:  K Nedeltchev; T A der Maur; D Georgiadis; M Arnold; V Caso; H P Mattle; G Schroth; L Remonda; M Sturzenegger; U Fischer; R W Baumgartner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

3.  Ischemic stroke in young adults: classification and risk factors.

Authors:  Anastasios Chatzikonstantinou; Marc E Wolf; Michael G Hennerici
Journal:  J Neurol       Date:  2011-09-17       Impact factor: 4.849

Review 4.  Juvenile Stroke.

Authors:  Florian Schöberl; Peter Arthur Ringleb; Reza Wakili; Sven Poli; Frank Arne Wollenweber; Lars Kellert
Journal:  Dtsch Arztebl Int       Date:  2017-08-07       Impact factor: 5.594

5.  Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow.

Authors:  Mary F Lopez; David A Sarracino; Maryann Vogelsang; Jennifer N Sutton; Michael Athanas; Bryan Krastins; Alejandra Garces; Amol Prakash; Scott Peterman; Zareh Demirjian; Ignacio Inglessis-Azuaje; Kathleen Feeney; Mikaela Elia; David McMullin; G William Dec; Igor Palacios; Eng H Lo; Ferdinand Buonanno; MingMing Ning
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

6.  Cerebral ischemia in young patients (under 45 years of age): clinical and neuroradiological follow-up.

Authors:  Rosalba Patella; Alessandra Spalloni; Marco Ferrari; Sara La Starza; Alessandro Bozzao; Maurizia Rasura
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

Review 7.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 8.  Drugs for stroke recovery: the example of amphetamines.

Authors:  Louise Martinsson; Staffan Eksborg
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Diagnostic Yield of Neck CT Angiography in Young Adults With Anterior Circulation Ischemic Stroke: A Community Based Study.

Authors:  William B Schenk; Waleed Brinjikji; Anthony S Larson; Deena M Nasr
Journal:  Neurohospitalist       Date:  2020-11-24

Review 10.  Expert opinion paper on cardiac imaging after ischemic stroke.

Authors:  Renate B Schnabel; Stephan Camen; Fabian Knebel; Andreas Hagendorff; Udo Bavendiek; Michael Böhm; Wolfram Doehner; Matthias Endres; Klaus Gröschel; Andreas Goette; Hagen B Huttner; Christoph Jensen; Paulus Kirchhof; Grigorios Korosoglou; Ulrich Laufs; Jan Liman; Caroline Morbach; Darius Günther Nabavi; Tobias Neumann-Haefelin; Waltraud Pfeilschifter; Sven Poli; Timolaos Rizos; Andreas Rolf; Joachim Röther; Wolf Rüdiger Schäbitz; Thorsten Steiner; Götz Thomalla; Rolf Wachter; Karl Georg Haeusler
Journal:  Clin Res Cardiol       Date:  2021-06-18       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.